Research Letter: Immune Cell Profiling in Lymphoma Patients Treated With CAR-T Cell Therapy and Nivolumab.

Khatib A; Grau A; Amit O; Zuckerman T; Fridberg G; Setter-Marco N; Zhelankin A; Beyar-Katz O; Ram R

doi:10.1016/j.jtct.2026.02.043

← 뒤로

Research Letter: Immune Cell Profiling in Lymphoma Patients Treated With CAR-T Cell Therapy and Nivolumab.

0/5 보강

Transplantation and cellular therapy 2026

Khatib A, Grau A, Amit O, Zuckerman T, Fridberg G, Setter-Marco N, Zhelankin A, Beyar-Katz O, Ram R

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris

APA Khatib A, Grau A, et al. (2026). Research Letter: Immune Cell Profiling in Lymphoma Patients Treated With CAR-T Cell Therapy and Nivolumab.. Transplantation and cellular therapy. https://doi.org/10.1016/j.jtct.2026.02.043

MLA Khatib A, et al.. "Research Letter: Immune Cell Profiling in Lymphoma Patients Treated With CAR-T Cell Therapy and Nivolumab.." Transplantation and cellular therapy, 2026.

PMID 41707852

DOI 10.1016/j.jtct.2026.02.043

같은 제1저자의 인용 많은 논문 (1)

The predictive value of lesion density in enhancing multiparametric MRI for detecting clinically significant prostate cancer.
Urologic oncology 2026